FierceBiotech

Lophius Biosciences Announces Granting of Another Key Patent in the U.S.

Lophius Biosciences Announces Granting of Another Key Patent in the U.S. Regensburg, Germany, November 15, 2010 / b3c newswire / - Lophius Biosciences announced today that the USTPO has granted the ...
technologynetworks

Lophius Biosciences Joins NEU² Program

Bionamics GmbH and Lophius Biosciences GmbH have announced that Lophius Biosciences has joined the NEU² program with a project addressing the development of T-Track® MS as a novel blood-based ...
technologynetworks

Lophius Biosciences Closes Financing Round and Expands Management Board

Lophius Biosciences announced the closing of a further financing round. With VRD GmbH and WIC GmbH two new investors will financially support the company alongside existing investors such as S-Refit, ...
pharmaphorum

New licensing deal signed to R&D innovative assays for infectious diseases

Oxford Immunotec, a medical diagnostic company developing tests in the fields of infectious and immunological disease, is to collaborate with Lophius Biosciences to develop novel T-cell based ...
FierceBiotech

Lophius Biosciences GmbH Appoints Dr. Robert Phelps As Director Business Operations

Regensburg, Germany, December 4, 2013 / B3C newswire / – Lophius Biosciences GmbH, a privately held biotech company developing and marketing innovative T cell-based diagnostic systems for the early ...